Angion Biomedica (NASDAQ: ANGN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.430 | -0.480 | -0.0500 | ||||
REV | 920.000K | 1.648M | 728.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Angion Biomedica (NASDAQ: ANGN) through any online brokerage.
There are no as such competitors for Angion Biomedica.
The latest price target for Angion Biomedica (NASDAQ: ANGN) was reported by Oppenheimer on Thursday, June 30, 2022. The analyst firm set a price target for 0.00 expecting ANGN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Angion Biomedica (NASDAQ: ANGN) is $1.12 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Angion Biomedica.
Angion Biomedica’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Angion Biomedica.
Angion Biomedica is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.